These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37707838)

  • 1. The Weight of Inevitability-My Journey With BRCA2.
    Wu KP
    JAMA Oncol; 2023 Nov; 9(11):1497-1498. PubMed ID: 37707838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA2: a 25-year journey from gene identification to targeted cancer treatment.
    Grinda T; Delaloge S
    Lancet Oncol; 2021 Jun; 22(6):763-764. PubMed ID: 34087125
    [No Abstract]   [Full Text] [Related]  

  • 3. Germline Testing of Patients With Non-small Cell Lung Cancers Demonstrating Incidentally Uncovered BRCA2 Apparent Pathogenic Germline Variants.
    Sorscher S
    Clin Lung Cancer; 2022 Nov; 23(7):e405-e407. PubMed ID: 35977876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ASO Author Reflections: High BRCA2 Gene Expression is Associated with Aggressive and Highly Proliferative Breast Cancer.
    Satyananda V; Oshi M; Endo I; Takabe K
    Ann Surg Oncol; 2021 Nov; 28(12):7366-7367. PubMed ID: 33966141
    [No Abstract]   [Full Text] [Related]  

  • 5. Cycling with BRCA2 from DNA repair to mitosis.
    Lee H
    Exp Cell Res; 2014 Nov; 329(1):78-84. PubMed ID: 25447315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA2 and pancreatic cancer.
    Naderi A; Couch FJ
    Int J Gastrointest Cancer; 2002; 31(1-3):99-106. PubMed ID: 12622420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aurora-A amplification associated with BRCA2 mutation in breast tumours.
    Bodvarsdottir SK; Hilmarsdottir H; Birgisdottir V; Steinarsdottir M; Jonasson JG; Eyfjord JE
    Cancer Lett; 2007 Apr; 248(1):96-102. PubMed ID: 16860930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of polyploidy by the BRCA2 protein.
    Sagulenko E; Savelyeva L; Ehemann V; Sagulenko V; Hofmann W; Arnold K; Claas A; Scherneck S; Schwab M
    Cancer Lett; 2007 Nov; 257(1):65-72. PubMed ID: 17686574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-links between Fanconi anaemia and BRCA2.
    West SC
    DNA Repair (Amst); 2003 Feb; 2(2):231-4. PubMed ID: 12531392
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Gunnarsdottir SR; Bjarnason H; Thorvaldsdottir B; Paland F; Steinarsdottir M; Eyfjörd JE; Bödvarsdottir SK
    Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The BRCA2-EMSY connection: implications for breast and ovarian tumorigenesis.
    Haber DA
    Cell; 2003 Nov; 115(5):507-8. PubMed ID: 14651841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of familial breast cancer with double heterozygosity for BRCA1 and BRCA2 genes.
    Nomizu T; Matsuzaki M; Katagata N; Kobayashi Y; Sakuma T; Monma T; Saito M; Watanabe F; Midorikawa S; Yamaguchi Y
    Breast Cancer; 2015 Sep; 22(5):557-61. PubMed ID: 23242612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique divergence of the breast cancer 2 (
    Michalak P; Kang L
    Hereditas; 2018; 155():34. PubMed ID: 30410429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive mutational analysis of BRCA1/BRCA2 for Korean breast cancer patients: evidence of a founder mutation.
    Seong MW; Cho S; Noh DY; Han W; Kim SW; Park CM; Park HW; Kim SY; Kim JY; Park SS
    Clin Genet; 2009 Aug; 76(2):152-60. PubMed ID: 19656164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and purification of a soluble region in the breast cancer susceptibility protein BRCA2.
    Finch D; Webb M
    Protein Expr Purif; 2005 Mar; 40(1):177-82. PubMed ID: 15721786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA2 gene mutation in cancer.
    Xie C; Luo J; He Y; Jiang L; Zhong L; Shi Y
    Medicine (Baltimore); 2022 Nov; 101(45):e31705. PubMed ID: 36397405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA2 mutations and triple-negative breast cancer.
    Meyer P; Landgraf K; Högel B; Eiermann W; Ataseven B
    PLoS One; 2012; 7(5):e38361. PubMed ID: 22666503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA1 and BRCA2 common mutations in iranian breast cancer patients: a meta analysis.
    Forat-Yazdi M; Neamatzadeh H; Sheikhha MH; Zare-Shehneh M; Fattahi M
    Asian Pac J Cancer Prev; 2015; 16(3):1219-24. PubMed ID: 25735359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA2: a universal recombinase regulator.
    Thorslund T; West SC
    Oncogene; 2007 Dec; 26(56):7720-30. PubMed ID: 18066084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.
    Jonkers J; Meuwissen R; van der Gulden H; Peterse H; van der Valk M; Berns A
    Nat Genet; 2001 Dec; 29(4):418-25. PubMed ID: 11694875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.